Overview

Study of Memantine to Treat Huntington's Disease

Status:
Completed
Trial end date:
2009-10-28
Target enrollment:
Participant gender:
Summary
To determine if memantine in doses of 10 mg BID affects memory, cognition, and behavior in patients with Huntington's disease (HD).
Phase:
Phase 4
Details
Lead Sponsor:
Jody Corey-Bloom, MD, PhD
University of California, San Diego
Collaborator:
Forest Laboratories
Treatments:
Memantine